Current Australian Grants

JDRF Grants

Name

Institution

Project Title

A/Prof. Shane Grey Garvan Institute of Medical Research Islet dependent tolerance for insulin independence without immunosuppression
Dr. Mugdha Joglekar University of Sydney Plasma RNA Evaluation and Diagnosis In Children progressing To Type 1 Diabetes (PREDICT T1D)
Dr. Katie Edwards Queensland University of Technology (QUT) Novel corneal nerve tests in diabetic neuropathy; growth rate and mapping
Dr. Emma Hamilton-Williams University of Queensland A genetic link between gut microbial flora and T1D susceptibility
Dr. Jane Mullaney University of Queensland A link between the gut microbiome and type 1 diabetes
Prof. Ranjeny Thomas University of Queensland Antigen-specific peptide immunotherapy targeting dendritic cells in type 1 diabetes
Dr. Ahmed Mehdi University of Queensland Developing models of T1D progression by integrating clinical and genomic data
Prof. Jennifer Couper University of Adelaide Early environmental determinants of pancreatic islet autoimmunity (ENDIA)
Prof. Jennifer Couper University of Adelaide Centre of Research Excellence for pancreatic beta-cell protection and preservation
Prof. Patrick Coates Royal Adelaide Hospital Vascularised Biodegradable Temporizing Matrix as an Alternative Site for Islet Transplantation
Dr. Christoph Hagemeyer Monash University Smart insulin delivery with glucose responsive nanomaterials
Dr. Gavin Higgins Baker IDI Heart & Diabetes Institute Impaired MnSOD causes dysregulation of mitophagy and accumulation of dysfunctional mitochondria in diabetic nephropathy
Prof. Karin Jandeleit-Dahm Baker IDI Heart & Diabetes Institute Nox5 is a new target for diabetic nephropathy
Dr. Bryna Chow Baker IDI Heart & Diabetes Institute The therapeutic potential of Compound 21 (Angiotensin II type 2 receptor agonist) in diabetic nephropathy
Prof. Anthony Purcell Monash University A peptidomics approach to understanding the fate and antigen presentation of post-translationally modified proteins in type 1 diabetes
A/Prof. Stuart Mannering St Vincent's Institute of Medical Research Molecular and functional analysis of human islet-infiltrating T cells
Prof. Len Harrison Walter and Eliza Hall Institute of Medical Research Methylation and miRNA expression as biomarkers in type 1 diabetes
Dr. John Wentworth Walter and Eliza Hall Institute of Medical Research Type 1 Diabetes TrialNet International Site - Australia/New Zealand
Prof. Len Harrison Walter and Eliza Hall Institute of Medical Research Intranasal Insulin Trial II
Dr. Sih Min tan Baker IDI Heart & Diabetes Institute Targeting the C5a-C5aR1 signaling axis in diabetic nephropathy
Prof. Mark Cooper Baker IDI Heart & Diabetes Institute New targets and therapies in diabetic complications
Dr. Jay Jha Baker IDI Heart & Diabetes Institute The relative role of NADPH oxidase-Nox5 versus Nox4 in type 1 diabetic nephropathy: in vitro and in vivo studies
A/Prof. Helen Thomas St Vincent's Institute of Medical Research Blocking the interaction between T cells and beta cells using JAK inhibitors
Dr.Eliana Marino Monash University Dietary Manipulation of Gut Microbial Metabolites Mitigate Type 1 Diabetes
A/Prof. Helen Thomas St Vincent's Institute of Medical Research Investigating whether endogenously-derived cytosolic nucleic acids trigger type 1 diabetes
Dr. Esteban Gurzov St Vincent's Institute of Medical Research The role of Protein Tyrosine Phosphatases in pancreatic beta cell function and survival
Dr. Thomas Loudovaris St Vincent's Institute of Medical Research  Pairing of genetically modified pig tissue with TheraCyte encapsulation devices
Prof. Tim Jones University of Western Australia Improving the lives of young people with Type 1 Diabetes Care using State-of-the-Art Therapies

 

Clinical Research Grants

JDRF is also awarding a number of grants through the Australian Type 1 Diabetes Clinical Research Network (T1DCRN). For more information, please see the T1DCRN website.